Allogene Therapeutics, Inc. ALLO
- ALLO-213 — Small Cell Lung Cancer
DLL3 (2 companies · 2 programs)
Companies with an active program directed at DLL3.
Zymeworks Inc. ZYME
- ZW209 — Small Cell Lung Cancer Preclinical
Companies with an active program directed at DLL3.